| Financial Year |
March 31 2023 |
| Monetary Funds |
2,437,271,303.65 |
| Held-for-trading Financial Assets |
38,996,547.70 |
| Notes Receivable |
58,834,574.26 |
| Accounts Receivable |
2,195,860,557.25 |
| Advances to Suppliers |
57,000,146.54 |
| Other Receivables |
143,725,655.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,177,483,987.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
196,615,962.02 |
| Total Current Assets |
8,664,963,933.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
45,789,810.73 |
| Investment Properties |
-- |
| Fixed Assetes |
4,995,548,810.57 |
| Under-construction Projects |
1,107,898,907.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
310,956,621.39 |
| R&D expenses |
-- |
| Goodwill |
147,215,994.51 |
| Long-Term Deferred and Prepaid Expenses |
320,694,872.58 |
| Deferred Income Tax Assets |
242,172,944.51 |
| Other Non-Current Assets |
750,691,847.46 |
| Sub-Total of Non-Current Assets |
8,595,348,298.30 |
| Total Assets |
17,260,312,231.93 |
| Short-Term Loans |
4,334,989,013.75 |
| Trading Financial liabilities |
1,048,000.00 |
| Notes Payable |
213,779,336.66 |
| Accounts Payable |
2,206,380,573.14 |
| Accounts Received In Advance |
454,425.36 |
| Employee Compensation Payable |
363,484,300.13 |
| Taxes Payable |
53,237,272.13 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
108,036,836.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,086,775,892.87 |
| Other Current Liabilities |
3,837,874.59 |
| Sub-Total of Current Liabilities |
8,460,628,150.93 |
| Long-term Loans |
2,183,646,666.64 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,515,718.48 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,942,309,705.43 |
| Total Liabilities |
11,402,937,856.36 |
| Paid-In Capital(Or Share Stock) |
1,201,027,716.00 |
| Capital Surplus |
2,573,191,721.15 |
| Surplus Reserve |
247,555,350.01 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,591,007,075.32 |
| Minority Stockholder's Interest |
252,298,589.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,605,075,785.90 |
| Owner's Equity（Stockholder's Equity） |
5,857,374,375.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,260,312,231.93 |
